FDA Recall D-0416-2026
K.C. Pharmaceuticals, Inc · Pomona, CA
Class II Ongoing 72 days on record
Product
Artificial Tears Sterile Lubricant Eye Drops (polyvinyl alcohol 0.5%, povidone 0.6%), 0.5 FL OZ (15 mL) bottles; a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO 43017, www.myleader.com, NDC 70000-0011-1; b) Good Sense, Distributed By: Perrigo Direct, Inc., Peachtree City, GA 30269, www.PerrigoDirect.com, NDC 50804-110-01; c) Good Neighbor Pharmacy, Distributed By AmerisourceBergen, Conshohocken, PA 19428, NDC 24385-006-05; d) TopCare health, DISTRIBUTED BY TOPCO ASSOCIATES LLC, ELKGROVE VILLAGE, IL 60007, UPC 0 36800 09331 7; e) Best Choice, PROUDLY DISTRIBUTED BY: VALU MERCHANDISERS, CO., KANSAS CITY, KS 66106, UPC 0 70038 47008 3; f) Kroger, DISTRIBUTED BY THE KROGER CO., CINCINNATI, OHIO 45202, UPC 0 11110 38600 7; g) P, DISTRIBUTED BY PUBLIX SUPER MARKETS, INC, LAKELAND, FL 33811, UPC 0 41415 00976 9; h) Quality Choice, Distributed by CDMA Inc, Novi, MI NDC 83324-189-14
Reason for recall
Lack of Assurance of Sterility
Recall record
- Recall number
D-0416-2026- Classification
- Class II
- Status
- Ongoing
- Voluntary or mandated
- Voluntary: Firm initiated
- Firm notification
- Distribution
- Nationwide in the US
- Recall initiated
- 2026-03-03
- Classified by FDA Center
- 2026-03-31
- FDA published
- 2026-04-08
- Recalling firm
- K.C. Pharmaceuticals, Inc
- Firm location
- Pomona, CA
Drug identification
- Brand name(s)
- LEADER ARTIFICIAL TEARS 15 ML, GOOD SENSE ARTIFICIAL TEARS, GOOD NEIGHBOR PHARMACY ARTIFICAL TEARS LUBRICANT EYE DROPS, QUALITY CHOICE ARTIFICIAL TEARS LUBRICANT EYE DROPS
- Generic name(s)
- POLYVINYL ALCOHOL, POVIDONE
- Manufacturer(s)
- Cardinal Health, Geiss, Destin & Dunn, Inc., AmerisourceBergen, Chain Drug Marketing Association, Inc.
- NDC(s)
70000-0011, 50804-110, 24385-006, 83324-189- Route(s)
- OPHTHALMIC
Operational response
Class II recalls indicate possible temporary or reversible health consequences. Remove affected lots from active dispensing. Segregate inventory. Check the firm’s recall notification for guidance on patient outreach.
For the official FDA enforcement record, see FDA's Recall Search.